[Effect of antitrichomonal treatment on the regression of cytologic para- and atypical lesions of the uterine cervix].
D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000150:complications; D002584:Cervix Uteri / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011230:Precancerous Conditions / Q000150:complications; D014247:Trichomonas Vaginitis / Q000188:drug therapy*; D002579:Uterine Cervical Erosion / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000150:complications*; D002575:Uterine Cervicitis / Q000150:complications
D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents
Dalsze badania nad wpływem leczenia przeciwrzesistkowego na regresje cytologicznych zmian para i atypowych szyjki macicy.